|Group 1 (2011–2012)||Group 2 (2015)|
|First-line therapies include CHCs or progestins||48%||61%|
|Ideally, CHCs should be administered continuously||27% prescribed CHCs were on continuous therapy||32% prescribed CHCs were on continuous therapy|
|Second-line therapies include GnRH agonists and the LNG-IUS||41% had tried second-line therapy||43% had tried second-line therapy|
|Hormonal addback should be prescribed for patients on GnRH agonist therapy||36%||54%|
|Surgery should be considered after failure of both first- and second-line medical therapy||48% had not tried second-line medical therapy before surgery||53% had not tried second-line medical therapy before surgery|
|Only surgeons who are capable of full resection should operate on endometriosis||38%||20%|
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Obstetrics and Gynaecology Canada
- Diagnosis and treatment of endometriosis.Am Fam Phys. 1999; 60: 1753
- Endometriosis and mechanisms of pelvic pain.J Min Invas Gynecol. 2009; 16: 540-550
- Endometriosis: diagnosis and management.J Obstet Gynaecol Can. 2010 Jul; 32: S1-S32